We are live on ! Find out more
CYTK icon

Cytokinetics

276 hedge funds and large institutions have $4.88B invested in Cytokinetics in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 109 increasing their positions, 82 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

356% more call options, than puts

Call options by funds: $48.3M | Put options by funds: $10.6M

33% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 82

16% more capital inflows, than outflows

Capital inflows: $421M | Capital outflows: $364M

1.83% more ownership

Funds ownership: 111.11% → 112.93% (+1.8%)

0% more funds holding

Funds holding: 276 → 276 (0)

3% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 35

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

Holders
276
Holders Change
–
Holders Change %
0%
% of All Funds
4.42%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.16%
New
34
Increased
109
Reduced
82
Closed
35
Calls
$48.3​M
Puts
$10.6​M
Net Calls
+$37.7​M
Net Calls Change
-⁠$3.12​M

CYTK Hedge Fund Activity: Q4 2022 in Review

276 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2022, worth a combined $4.88B — down 3.9% from $5.08B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CYTK and 34 opened new positions — a net loss of 1 holder — while 82 trimmed existing stakes and 109 added.

The largest buyer was Wellington Management Group, adding an estimated $73.4M. The largest seller was Driehaus Capital Management, cutting an estimated $53.4M.

  • 276 institutional investors held Cytokinetics (CYTK) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $4.88B of Cytokinetics stock for Q4 2022, down 3.9% quarter-over-quarter.
  • 34 funds opened new Cytokinetics positions in Q4 2022 and 35 closed out, a net change of -1 holder.
  • The largest Cytokinetics buyer in Q4 2022 was Wellington Management Group, an estimated $73.4M added.
  • The largest Cytokinetics seller in Q4 2022 was Driehaus Capital Management, an estimated $53.4M sold.

Based on aggregated 13F filings for Q4 2022.